Cargando…
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis
Hypercoagulable state and disorganized angiogenesis are two conspicuous characteristics during tumor progression. There are a considerable number of clinical trials focusing on the effects of anticoagulant and antiangiogenic drugs on the survival of cancer patients. Favorable outcomes have been obse...
Autores principales: | Wang, Ji, Zhu, Chengchu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973715/ https://www.ncbi.nlm.nih.gov/pubmed/27536135 http://dx.doi.org/10.2147/OTT.S103184 |
Ejemplares similares
-
Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer
por: Wu, Li Cun, et al.
Publicado: (2008) -
Chemotherapy in combination with pembrolizumab and antiangiogenesis
in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two
case reports
por: Zhou, Daibing, et al.
Publicado: (2021) -
Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016) -
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
por: Jones, P H, et al.
Publicado: (2004) -
Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003)